Amgen

News
AmgenLandscape 2

Amgen and UCB re-file Evenity for US approval

Amgen and UCB have resubmitted their application for US approval of Evenity as an osteoporosis treatment, hoping that the additional data they have provided will help overcome the FDA’s pre

News
A sad young woman is sitting in her kitchen with a headache

Lilly joins CGRP race to cure migraine

Eli Lilly are gearing up to announce details from the latest Emgality analysis, which can potentially push the biotech to the leading pack of the migraine cure race, among Allergan, Amgen a

Views & Analysis
Top pharmaceutical companies 2017

Top pharmaceutical companies in the world in 2017

The rankings of the top pharmaceutical companies in the world in 2017 presented a mixed picture, with stability for some of the 25 largest firms as others saw their value fall.